BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Lambert-Eaton Myasthenic Syndrome

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Lambert-Eaton Myasthenic Syndrome:

Pubmed Logo
Chapter 9 The Lambert-Eaton myasthenic syndrome.
Lafora disease (LD) is the most severe form of Progressive Myoclonus...
18th July, 2008
Duke University Medical School, Durham, NC, USA. Handb Clin Neurol. 2008;91:273-83.
DOI Direct Link
Using immunoglobulins in muscular disease treatment.
BACKGROUND: Intravenous immunoglobulins (IVIg) have been proven in the...
11th July, 2008
Department of Neurology, Hannover Medical School, Carl-Neuberg-Street 1, Expert Opin Biol Ther. 2008 Aug;8(8):1143-50.
DOI Direct Link
Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung.
Lambert-Eaton syndrome (LES) is an immune-mediated disorder of the...
10th July, 2008
The Neurological Institutes, University Hospitals Case Medical Center, Muscle Nerve. 2008 Jun;37(6):786-9.
DOI Direct Link
Lambert-Eaton myasthenic syndrome in childhood.
Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder of...
1st July, 2008
Department of Neurology, Medical University of Warsaw, Poland. Eur J Paediatr Neurol. 2008 Jun 26;.
DOI Direct Link
Lambert-Eaton Myasthenic Syndrome: Tumor versus Nontumor Forms.
Half the patients with Lambert-Eaton myasthenic syndrome (LEMS) have a...
24th June, 2008
Department of Neurology, K5-Q, Leiden University Medical Center, PO Box Ann N Y Acad Sci. 2008 Jun;1132:129-34.
DOI Direct Link

View more research publications.

Lambert-Eaton Myasthenic Syndrome Clinical Trials:

Clinical Trials Logo
Treatment of Lambert-Eaton Syndrome With 3,4 DAP
Lambert Eaton Myasthenic Syndrome

Lambert-Eaton Myasthenic Syndrome Patents:

USPTO Logo
US Patent No.Title
6936688 Human chemokine beta-10 mutant polypeptides
7063950 Nucleic acids encoding human calcium channel and methods of use thereof
7067512 Substituted 1,4-benzodiazepines and uses thereof
7070803 Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine
7078186 Apoptosis related polynucleotides, polypeptides, and antibodies

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Lambert-Eaton Myasthenic Syndrome scientists - we have details of around 66 individuals working on Lambert-Eaton Myasthenic Syndrome .


This page has been viewed 99 times
Recent Search Terms used to find this page: what is the drug eaton | ephedrine myasthenia | lambert eaton myasthenic syndrome | lambert-eaton myasthenic syndrome | lambert eaton physiology | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Lambert-Eaton Myasthenic Syndrome across BioPortfolio, or bestselling Lambert-Eaton Myasthenic Syndrome books or recently published Lambert-Eaton Myasthenic Syndrome books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional